NCT04038060 - The PrEP (Pre-exposure Prophylaxis) SMART Study | Biotech Hunter

Enrollment

350

Participants

Timeline

Start Date

May 16, 2019

Primary Completion Date

October 27, 2021

Study Completion Date

January 25, 2022

Conditions

HIV/AIDS

Interventions

BEHAVIORAL

WhatsApp Group

Participants will receive peer adherence support through WhatsApp groups

BEHAVIORAL

2-way SMS

Participants will receive healthcare worker adherence support through 2-way SMS

BEHAVIORAL

Drug level feedback

Participants will receive adherence counseling based on tenofovir drug levels

BEHAVIORAL

Monthly counseling sessions

Participants will receive monthly counseling on a variety of issues that may be impacting their PrEP adherence

Trial Locations (1)

Wits Reproductive Health and HIV Institute, Johannesburg

All Listed Sponsors

collaborator

Wits Reproductive Health and HIV Institute

OTHER

collaborator

National Institute of Mental Health (NIMH)

NIH

lead

University of Washington

OTHER